These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19243013)

  • 1. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells.
    Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S
    Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells.
    Celius T; Garberg P; Lundgren B
    Biochem Biophys Res Commun; 2004 Nov; 324(1):365-71. PubMed ID: 15465028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines.
    Siissalo S; Laitinen L; Koljonen M; Vellonen KS; Kortejärvi H; Urtti A; Hirvonen J; Kaukonen AM
    Eur J Pharm Biopharm; 2007 Sep; 67(2):548-54. PubMed ID: 17475454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers.
    Endter S; Becker U; Daum N; Huwer H; Lehr CM; Gumbleton M; Ehrhardt C
    Cell Tissue Res; 2007 Apr; 328(1):77-84. PubMed ID: 17165089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells.
    Peng Z; Xiao Z; Wang Y; Liu P; Cai Y; Lu S; Feng W; Han ZC
    Cancer Gene Ther; 2004 Nov; 11(11):707-12. PubMed ID: 15375375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of capsaicin on P-gp function and expression in Caco-2 cells.
    Han Y; Tan TM; Lim LY
    Biochem Pharmacol; 2006 Jun; 71(12):1727-34. PubMed ID: 16674925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective downregulation of the MDR1 gene product in Caco-2 cells by stable transfection to prove its relevance in secretory drug transport.
    Hilgendorf C; Spahn-Langguth H; Rhedin M; Regårdh CG; Löwenadler B; Langguth P
    Mol Pharm; 2005; 2(1):64-73. PubMed ID: 15804179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
    Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D
    Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-Glycoprotein expression in human retinal pigment epithelium cell lines.
    Constable PA; Lawrenson JG; Dolman DE; Arden GB; Abbott NJ
    Exp Eye Res; 2006 Jul; 83(1):24-30. PubMed ID: 16530756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
    Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
    Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide does not interact with P-glycoprotein.
    Zimmermann C; Gutmann H; Drewe J
    Cancer Chemother Pharmacol; 2006 May; 57(5):599-606. PubMed ID: 16136308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
    Stege A; Priebsch A; Nieth C; Lage H
    Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells.
    Flescher E; Rotem R; Kwon P; Azare J; Jaspers I; Cohen D
    Anticancer Res; 2000; 20(6B):4441-4. PubMed ID: 11205285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation.
    Sun M; Kingdom J; Baczyk D; Lye SJ; Matthews SG; Gibb W
    Placenta; 2006; 27(6-7):602-9. PubMed ID: 16143395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp.
    Wang XD; Meng MX; Gao LB; Liu T; Xu Q; Zeng S
    Int J Pharm; 2009 Aug; 378(1-2):1-8. PubMed ID: 19465099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone export from cells: contribution of P-glycoprotein.
    Mitchell AM; Tom M; Mortimer RH
    J Endocrinol; 2005 Apr; 185(1):93-8. PubMed ID: 15817830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.